Axiora Medical
Axiora Medical
Premium clinical implants and specialized instrumentation tailored for Canadian hospital procurement standards and orthopaedic trauma care.
The Canadian healthcare environment, governed by federal guidelines through Health Canada and executed by provincial health authorities (such as Ontario Health, Alberta Health Services, and BC Clinical Commons), demands the highest benchmarks of quality, compliance, and supply chain reliability. In recent years, orthopedic surgery units from Toronto to Vancouver have faced compounding pressure from aging populations, increased winter-related trauma cases (slips and fractures on ice), and rising wait times for elective arthroplasties. Cannulated screws—vital for minimally invasive stabilization of femoral neck, patella, talus, and calcaneus fractures—represent one of the most critical procurement lines for surgical centers.
Historically dependent on multi-national orthopedic giants, Canadian medical device distributors and Group Purchasing Organizations (GPOs) such as HealthPRO and Plexxus are actively seeking qualified, cost-effective, and regulation-compliant manufacturing alternatives. By bridging precision CNC engineering with direct supply and robust OEM/ODM capabilities, Axiora Medical Technology offers the Canadian market a vital buffer against global supply chain disruptions while meeting stringent technical specifications.
Canada’s population is aging rapidly. Geriatric hip fractures represent an ongoing orthopedic emergency. Minimally invasive fixation using 6.5mm and 7.3mm titanium cannulated screws reduces hospital stays and postoperative complications under the Medicare framework.
Provincial health budgets operate under strict cost-containment. Axiora provides direct manufacturer pricing on high-grade titanium and stainless steel trauma hardware, reducing total cost of care without compromising surgeon trust.
Long lead times and stockouts of critical implant sizes disrupt operating room scheduling. Axiora guarantees stable production runs and rapid international logistics, backing Canadian distributors with responsive inventory management.
A cannulated screw is more than a fastener; it is a bio-compatible, load-bearing medical instrument designed for exact clinical deployment. Axiora's design philosophy targets the mechanical properties required for rigid internal fixation:
| Strategic Core Metric | Operational Specifications & Axiora Standards |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 (Consolidating 15 Years of Advanced Industrial Experience) |
| Factory Infrastructure | 18,600 m² Facility utilizing High-Precision CNC longitudinal cutting machines |
| Annual Export Revenue | USD 26 Million (Serving premium clinical accounts globally) |
| Quality Inspection Protocols | 100% Finished Product Inspection & Strict Incoming Material Traceability |
| Measurement & Validation Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing, Fatigue Testing |
| QA / QC Personnel | 48 Quality Engineers and Inspectors |
| Regulatory Capabilities | Support for Health Canada MDL submissions, MDEL registration, and ISO 13485:2016 Certification |
| Research & Development | 86 Specialized R&D Engineers releasing over 120 new products/configurations annually |
From raw medical-grade bar stocks to final sterile packaging, explore our audited manufacturing steps for high-reliability trauma implants.
Distributing implants in Canada requires strict conformity to the Canadian Medical Devices Regulations (CMDR SOR/98-282). Orthopedic fixation implants such as locking plates, intramedullary nails, and cannulated screws are categorized under Class III Medical Devices by Health Canada. This classification mandates the manufacturer to hold a valid ISO 13485:2016 (MDSAP) certificate and submit a comprehensive medical device license (MDL) application detailed with mechanical performance tests, sterilization validations, and biocompatibility evidence.
We provide full technical documentation and clinical study dossiers to support Canadian distributors in filing and securing Class III MDL registration, ensuring smooth customs clearance through the Canada Border Services Agency (CBSA).
All implants undergo rigorous verification. Cannulated screws are tested for axial pull-out strength, driving torque, and torsional properties in alignment with ASTM F543 benchmarks and ISO 5835 specifications.
Our ISO Class 7 (Class 10,000) aseptic packaging suites ensure that non-sterile and sterile implants arrive at Canadian central sterile services departments (CSSD) meeting the highest sterility assurance levels.
How Axiora continues to innovate, developing materials and designs to lower surgical failure rates and speed up osteointegration.
As the orthopaedic industry transitions from basic mechanical fixation to biologically active stabilization, our R&D roadmap focuses on three major advancements:
Transitioning to Type II titanium anodization on locking screws and plates, which increases wear resistance, reduces bone friction, and mitigates the risk of cold welding between screw heads and plates.
Integrating StarDrive (hexalobe) recess geometries across all cannulated screw designs to maximize torque transmission and eliminate stripping issues commonly seen during high-density bone insertion.
Collaborating with top material science universities to research bio-absorbable polymers (PLGA/HA composite material) for pediatric trauma screw application, avoiding a second implant removal surgery.
Browse our global export range of ISO 13485 surgical tools, screws, and arthroscopic repair sets engineered for modern surgical needs.
Answers to common clinical, logistical, and technical questions regarding the supply of implants to the Canadian market.
A: Our manufacturing plant operates under ISO 13485 (Medical Devices - Quality Management Systems). We actively collaborate with licensed Canadian importers and distributors. We provide complete technical documentation (such as biocompatibility data, dynamic/static mechanical testing reports, and ISO Class 7 cleanliness validation reports) to support the Class III Medical Device License (MDL) registration with Health Canada.
A: Axiora utilizes exclusively medical-grade titanium alloy Ti-6Al-4V ELI (Extra Low Interstitials) conforming to ASTM F136 specifications. This medical grade offers superior biocompatibility, high corrosion resistance, and high fatigue limits, making it perfect for permanent or temporary internal fixation.
A: Yes. With our team of 86 R&D engineers and an 18,600 m² factory equipped with advanced CNC longitudinal cutting lathes, we specialize in OEM/ODM production. We can work directly from your engineering blueprints, design drafts, or reverse-engineer original samples while ensuring full tolerance compliance down to ±0.005mm.
A: For standard catalog inventory items, products are ready for dispatch within 5–10 business days. For customized OEM production lines, the lead time typically ranges from 30 to 45 days. We work with leading air and sea freight partners to deliver efficiently to key Canadian hubs including Toronto, Montreal, Calgary, and Vancouver.
A: Implants undergo two separate stages of ultrasonic washing using medical-grade purified water. They are packaged in our ISO Class 7 cleanroom environment. Cleanliness is audited through periodic bioburden, endotoxin, and particle contamination tests to comply with strict international standards.
Ready to optimize your orthopedic supply chain in Canada?
Send Inquiry Now
